Rockwell Medical Inc (RMTI)
1.58
-0.05
(-3.07%)
USD |
NASDAQ |
May 03, 16:00
1.59
+0.01
(+0.63%)
After-Hours: 20:00
Rockwell Medical Free Cash Flow: -9.696M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.696M |
| September 30, 2023 | -9.806M |
| June 30, 2023 | -7.256M |
| March 31, 2023 | -11.39M |
| December 31, 2022 | -17.21M |
| September 30, 2022 | -26.15M |
| June 30, 2022 | -32.14M |
| March 31, 2022 | -31.36M |
| December 31, 2021 | -34.06M |
| September 30, 2021 | -33.56M |
| June 30, 2021 | -31.96M |
| March 31, 2021 | -36.48M |
| December 31, 2020 | -30.69M |
| September 30, 2020 | -27.48M |
| June 30, 2020 | -28.45M |
| March 31, 2020 | -29.54M |
| December 31, 2019 | -28.59M |
| September 30, 2019 | -29.34M |
| June 30, 2019 | -27.80M |
| March 31, 2019 | -22.45M |
| December 31, 2018 | -21.41M |
| September 30, 2018 | -21.01M |
| June 30, 2018 | -20.48M |
| March 31, 2018 | -22.32M |
| December 31, 2017 | -22.80M |
| Date | Value |
|---|---|
| September 30, 2017 | -16.50M |
| June 30, 2017 | -18.80M |
| March 31, 2017 | -16.78M |
| December 31, 2016 | -12.81M |
| September 30, 2016 | -13.59M |
| June 30, 2016 | -10.76M |
| March 31, 2016 | -12.02M |
| December 31, 2015 | -14.14M |
| September 30, 2015 | 3.608M |
| June 30, 2015 | 7.702M |
| March 31, 2015 | 10.88M |
| December 31, 2014 | 3.573M |
| September 30, 2014 | -22.21M |
| June 30, 2014 | -32.21M |
| March 31, 2014 | -50.55M |
| December 31, 2013 | -51.32M |
| September 30, 2013 | -49.77M |
| June 30, 2013 | -49.37M |
| March 31, 2013 | -34.33M |
| December 31, 2012 | -31.25M |
| September 30, 2012 | -28.12M |
| June 30, 2012 | -21.21M |
| March 31, 2012 | -15.06M |
| December 31, 2011 | -11.35M |
| September 30, 2011 | -6.999M |
Free Cash Flow Range, Past 5 Years
-36.48M
Minimum
Mar 2021
-7.256M
Maximum
Jun 2023
-25.42M
Average
-28.59M
Median
Dec 2019
Free Cash Flow Benchmarks
| Cyclacel Pharmaceuticals Inc | -16.12M |
| Oragenics Inc | -7.291M |
| Alpine Immune Sciences Inc | -79.50M |
| Corvus Pharmaceuticals Inc | -23.97M |
| MAIA Biotechnology Inc | -13.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.043M |
| Cash from Investing (Quarterly) | 2.008M |
| Cash from Financing (Quarterly) | -0.742M |
| Free Cash Flow Per Share (Quarterly) | -0.003 |
| Free Cash Flow to Equity (Quarterly) | 0.827M |
| Free Cash Flow Yield | -26.37% |